Global Menopausal Hormone Therapy Supply, Demand and Key Producers, 2023-2029
The global Menopausal Hormone Therapy market size is expected to reach $ 35970 million by 2029, rising at a market growth of 5.8% CAGR during the forecast period (2023-2029).
The menopausal hormone therapy (MHT) market is expected to grow significantly in the coming years, driven by a number of factors, including:
Rising awareness of the benefits of menopausal hormone therapy: There is a growing awareness of the benefits of menopausal hormone therapy, such as relief of menopausal symptoms, reduced risk of osteoporosis, and improved cardiovascular health. This is also driving the demand for menopausal hormone therapy.
Changing social norms: Social norms are changing around menopause, and women are becoming more open to discussing their symptoms and seeking treatment. This is also driving the demand for menopausal hormone therapy.
The North American region is expected to be the largest market for menopausal hormone therapy, followed by Europe and the Asia Pacific region. The growth of the market in the North American region is being driven by the high prevalence of menopause and the easy availability of menopausal hormone therapy products.
Overall, the menopausal hormone therapy market is expected to grow significantly in the coming years, driven by increasing population of menopausal women, rising awareness of the benefits of menopausal hormone therapy, and changing social norms.
Menopausal hormone therapy (MHT) is a treatment that uses hormones to relieve the symptoms of menopause. Menopause is a natural process that occurs when a woman's ovaries stop producing estrogen and progesterone. This can cause a variety of symptoms, including hot flashes, night sweats, vaginal dryness, mood swings, and difficulty sleeping.
This report studies the global Menopausal Hormone Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Menopausal Hormone Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Menopausal Hormone Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Menopausal Hormone Therapy total market, 2018-2029, (USD Million)
Global Menopausal Hormone Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Menopausal Hormone Therapy total market, key domestic companies and share, (USD Million)
Global Menopausal Hormone Therapy revenue by player and market share 2018-2023, (USD Million)
Global Menopausal Hormone Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Menopausal Hormone Therapy total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Menopausal Hormone Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Menopausal Hormone Therapy market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Menopausal Hormone Therapy Market, By Region:
1. How big is the global Menopausal Hormone Therapy market?
2. What is the demand of the global Menopausal Hormone Therapy market?
3. What is the year over year growth of the global Menopausal Hormone Therapy market?
4. What is the total value of the global Menopausal Hormone Therapy market?
5. Who are the major players in the global Menopausal Hormone Therapy market?
The menopausal hormone therapy (MHT) market is expected to grow significantly in the coming years, driven by a number of factors, including:
Rising awareness of the benefits of menopausal hormone therapy: There is a growing awareness of the benefits of menopausal hormone therapy, such as relief of menopausal symptoms, reduced risk of osteoporosis, and improved cardiovascular health. This is also driving the demand for menopausal hormone therapy.
Changing social norms: Social norms are changing around menopause, and women are becoming more open to discussing their symptoms and seeking treatment. This is also driving the demand for menopausal hormone therapy.
The North American region is expected to be the largest market for menopausal hormone therapy, followed by Europe and the Asia Pacific region. The growth of the market in the North American region is being driven by the high prevalence of menopause and the easy availability of menopausal hormone therapy products.
Overall, the menopausal hormone therapy market is expected to grow significantly in the coming years, driven by increasing population of menopausal women, rising awareness of the benefits of menopausal hormone therapy, and changing social norms.
Menopausal hormone therapy (MHT) is a treatment that uses hormones to relieve the symptoms of menopause. Menopause is a natural process that occurs when a woman's ovaries stop producing estrogen and progesterone. This can cause a variety of symptoms, including hot flashes, night sweats, vaginal dryness, mood swings, and difficulty sleeping.
This report studies the global Menopausal Hormone Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Menopausal Hormone Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Menopausal Hormone Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Menopausal Hormone Therapy total market, 2018-2029, (USD Million)
Global Menopausal Hormone Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Menopausal Hormone Therapy total market, key domestic companies and share, (USD Million)
Global Menopausal Hormone Therapy revenue by player and market share 2018-2023, (USD Million)
Global Menopausal Hormone Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Menopausal Hormone Therapy total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Menopausal Hormone Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Menopausal Hormone Therapy market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Menopausal Hormone Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Estrogen
- Progesterone
- Hospital
- Clinic
- Others
- Eli Lilly
- Pfizer
- AbbVie
- Novo Nordisk
- Merck KGaA
- Mylan
- Bayer
- Teva
- Novartis
- Abbott
- Roche
- Endo International
- Ipsen
- ANI Pharmaceuticals
- TherapeuticsMD
1. How big is the global Menopausal Hormone Therapy market?
2. What is the demand of the global Menopausal Hormone Therapy market?
3. What is the year over year growth of the global Menopausal Hormone Therapy market?
4. What is the total value of the global Menopausal Hormone Therapy market?
5. Who are the major players in the global Menopausal Hormone Therapy market?
1 SUPPLY SUMMARY
1.1 Menopausal Hormone Therapy Introduction
1.2 World Menopausal Hormone Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Menopausal Hormone Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Menopausal Hormone Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Menopausal Hormone Therapy Market Size (2018-2029)
1.3.3 China Menopausal Hormone Therapy Market Size (2018-2029)
1.3.4 Europe Menopausal Hormone Therapy Market Size (2018-2029)
1.3.5 Japan Menopausal Hormone Therapy Market Size (2018-2029)
1.3.6 South Korea Menopausal Hormone Therapy Market Size (2018-2029)
1.3.7 ASEAN Menopausal Hormone Therapy Market Size (2018-2029)
1.3.8 India Menopausal Hormone Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Menopausal Hormone Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Menopausal Hormone Therapy Major Market Trends
2 DEMAND SUMMARY
2.1 World Menopausal Hormone Therapy Consumption Value (2018-2029)
2.2 World Menopausal Hormone Therapy Consumption Value by Region
2.2.1 World Menopausal Hormone Therapy Consumption Value by Region (2018-2023)
2.2.2 World Menopausal Hormone Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Menopausal Hormone Therapy Consumption Value (2018-2029)
2.4 China Menopausal Hormone Therapy Consumption Value (2018-2029)
2.5 Europe Menopausal Hormone Therapy Consumption Value (2018-2029)
2.6 Japan Menopausal Hormone Therapy Consumption Value (2018-2029)
2.7 South Korea Menopausal Hormone Therapy Consumption Value (2018-2029)
2.8 ASEAN Menopausal Hormone Therapy Consumption Value (2018-2029)
2.9 India Menopausal Hormone Therapy Consumption Value (2018-2029)
3 WORLD MENOPAUSAL HORMONE THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Menopausal Hormone Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Menopausal Hormone Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Menopausal Hormone Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Menopausal Hormone Therapy in 2022
3.3 Menopausal Hormone Therapy Company Evaluation Quadrant
3.4 Menopausal Hormone Therapy Market: Overall Company Footprint Analysis
3.4.1 Menopausal Hormone Therapy Market: Region Footprint
3.4.2 Menopausal Hormone Therapy Market: Company Product Type Footprint
3.4.3 Menopausal Hormone Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Menopausal Hormone Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Menopausal Hormone Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Menopausal Hormone Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Menopausal Hormone Therapy Consumption Value Comparison
4.2.1 United States VS China: Menopausal Hormone Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Menopausal Hormone Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Menopausal Hormone Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Menopausal Hormone Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Menopausal Hormone Therapy Revenue, (2018-2023)
4.4 China Based Companies Menopausal Hormone Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Menopausal Hormone Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Menopausal Hormone Therapy Revenue, (2018-2023)
4.5 Rest of World Based Menopausal Hormone Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Menopausal Hormone Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Menopausal Hormone Therapy Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Menopausal Hormone Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Estrogen
5.2.2 Progesterone
5.3 Market Segment by Type
5.3.1 World Menopausal Hormone Therapy Market Size by Type (2018-2023)
5.3.2 World Menopausal Hormone Therapy Market Size by Type (2024-2029)
5.3.3 World Menopausal Hormone Therapy Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Menopausal Hormone Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Menopausal Hormone Therapy Market Size by Application (2018-2023)
6.3.2 World Menopausal Hormone Therapy Market Size by Application (2024-2029)
6.3.3 World Menopausal Hormone Therapy Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Eli Lilly
7.1.1 Eli Lilly Details
7.1.2 Eli Lilly Major Business
7.1.3 Eli Lilly Menopausal Hormone Therapy Product and Services
7.1.4 Eli Lilly Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Eli Lilly Recent Developments/Updates
7.1.6 Eli Lilly Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Menopausal Hormone Therapy Product and Services
7.2.4 Pfizer Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Menopausal Hormone Therapy Product and Services
7.3.4 AbbVie Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Novo Nordisk
7.4.1 Novo Nordisk Details
7.4.2 Novo Nordisk Major Business
7.4.3 Novo Nordisk Menopausal Hormone Therapy Product and Services
7.4.4 Novo Nordisk Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novo Nordisk Recent Developments/Updates
7.4.6 Novo Nordisk Competitive Strengths & Weaknesses
7.5 Merck KGaA
7.5.1 Merck KGaA Details
7.5.2 Merck KGaA Major Business
7.5.3 Merck KGaA Menopausal Hormone Therapy Product and Services
7.5.4 Merck KGaA Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Merck KGaA Recent Developments/Updates
7.5.6 Merck KGaA Competitive Strengths & Weaknesses
7.6 Mylan
7.6.1 Mylan Details
7.6.2 Mylan Major Business
7.6.3 Mylan Menopausal Hormone Therapy Product and Services
7.6.4 Mylan Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Mylan Recent Developments/Updates
7.6.6 Mylan Competitive Strengths & Weaknesses
7.7 Bayer
7.7.1 Bayer Details
7.7.2 Bayer Major Business
7.7.3 Bayer Menopausal Hormone Therapy Product and Services
7.7.4 Bayer Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Bayer Recent Developments/Updates
7.7.6 Bayer Competitive Strengths & Weaknesses
7.8 Teva
7.8.1 Teva Details
7.8.2 Teva Major Business
7.8.3 Teva Menopausal Hormone Therapy Product and Services
7.8.4 Teva Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Teva Recent Developments/Updates
7.8.6 Teva Competitive Strengths & Weaknesses
7.9 Novartis
7.9.1 Novartis Details
7.9.2 Novartis Major Business
7.9.3 Novartis Menopausal Hormone Therapy Product and Services
7.9.4 Novartis Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Novartis Recent Developments/Updates
7.9.6 Novartis Competitive Strengths & Weaknesses
7.10 Abbott
7.10.1 Abbott Details
7.10.2 Abbott Major Business
7.10.3 Abbott Menopausal Hormone Therapy Product and Services
7.10.4 Abbott Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Abbott Recent Developments/Updates
7.10.6 Abbott Competitive Strengths & Weaknesses
7.11 Roche
7.11.1 Roche Details
7.11.2 Roche Major Business
7.11.3 Roche Menopausal Hormone Therapy Product and Services
7.11.4 Roche Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Roche Recent Developments/Updates
7.11.6 Roche Competitive Strengths & Weaknesses
7.12 Endo International
7.12.1 Endo International Details
7.12.2 Endo International Major Business
7.12.3 Endo International Menopausal Hormone Therapy Product and Services
7.12.4 Endo International Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Endo International Recent Developments/Updates
7.12.6 Endo International Competitive Strengths & Weaknesses
7.13 Ipsen
7.13.1 Ipsen Details
7.13.2 Ipsen Major Business
7.13.3 Ipsen Menopausal Hormone Therapy Product and Services
7.13.4 Ipsen Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Ipsen Recent Developments/Updates
7.13.6 Ipsen Competitive Strengths & Weaknesses
7.14 ANI Pharmaceuticals
7.14.1 ANI Pharmaceuticals Details
7.14.2 ANI Pharmaceuticals Major Business
7.14.3 ANI Pharmaceuticals Menopausal Hormone Therapy Product and Services
7.14.4 ANI Pharmaceuticals Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 ANI Pharmaceuticals Recent Developments/Updates
7.14.6 ANI Pharmaceuticals Competitive Strengths & Weaknesses
7.15 TherapeuticsMD
7.15.1 TherapeuticsMD Details
7.15.2 TherapeuticsMD Major Business
7.15.3 TherapeuticsMD Menopausal Hormone Therapy Product and Services
7.15.4 TherapeuticsMD Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 TherapeuticsMD Recent Developments/Updates
7.15.6 TherapeuticsMD Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Menopausal Hormone Therapy Industry Chain
8.2 Menopausal Hormone Therapy Upstream Analysis
8.3 Menopausal Hormone Therapy Midstream Analysis
8.4 Menopausal Hormone Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Menopausal Hormone Therapy Introduction
1.2 World Menopausal Hormone Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Menopausal Hormone Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Menopausal Hormone Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Menopausal Hormone Therapy Market Size (2018-2029)
1.3.3 China Menopausal Hormone Therapy Market Size (2018-2029)
1.3.4 Europe Menopausal Hormone Therapy Market Size (2018-2029)
1.3.5 Japan Menopausal Hormone Therapy Market Size (2018-2029)
1.3.6 South Korea Menopausal Hormone Therapy Market Size (2018-2029)
1.3.7 ASEAN Menopausal Hormone Therapy Market Size (2018-2029)
1.3.8 India Menopausal Hormone Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Menopausal Hormone Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Menopausal Hormone Therapy Major Market Trends
2 DEMAND SUMMARY
2.1 World Menopausal Hormone Therapy Consumption Value (2018-2029)
2.2 World Menopausal Hormone Therapy Consumption Value by Region
2.2.1 World Menopausal Hormone Therapy Consumption Value by Region (2018-2023)
2.2.2 World Menopausal Hormone Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Menopausal Hormone Therapy Consumption Value (2018-2029)
2.4 China Menopausal Hormone Therapy Consumption Value (2018-2029)
2.5 Europe Menopausal Hormone Therapy Consumption Value (2018-2029)
2.6 Japan Menopausal Hormone Therapy Consumption Value (2018-2029)
2.7 South Korea Menopausal Hormone Therapy Consumption Value (2018-2029)
2.8 ASEAN Menopausal Hormone Therapy Consumption Value (2018-2029)
2.9 India Menopausal Hormone Therapy Consumption Value (2018-2029)
3 WORLD MENOPAUSAL HORMONE THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Menopausal Hormone Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Menopausal Hormone Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Menopausal Hormone Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Menopausal Hormone Therapy in 2022
3.3 Menopausal Hormone Therapy Company Evaluation Quadrant
3.4 Menopausal Hormone Therapy Market: Overall Company Footprint Analysis
3.4.1 Menopausal Hormone Therapy Market: Region Footprint
3.4.2 Menopausal Hormone Therapy Market: Company Product Type Footprint
3.4.3 Menopausal Hormone Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Menopausal Hormone Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Menopausal Hormone Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Menopausal Hormone Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Menopausal Hormone Therapy Consumption Value Comparison
4.2.1 United States VS China: Menopausal Hormone Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Menopausal Hormone Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Menopausal Hormone Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Menopausal Hormone Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Menopausal Hormone Therapy Revenue, (2018-2023)
4.4 China Based Companies Menopausal Hormone Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Menopausal Hormone Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Menopausal Hormone Therapy Revenue, (2018-2023)
4.5 Rest of World Based Menopausal Hormone Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Menopausal Hormone Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Menopausal Hormone Therapy Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Menopausal Hormone Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Estrogen
5.2.2 Progesterone
5.3 Market Segment by Type
5.3.1 World Menopausal Hormone Therapy Market Size by Type (2018-2023)
5.3.2 World Menopausal Hormone Therapy Market Size by Type (2024-2029)
5.3.3 World Menopausal Hormone Therapy Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Menopausal Hormone Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Menopausal Hormone Therapy Market Size by Application (2018-2023)
6.3.2 World Menopausal Hormone Therapy Market Size by Application (2024-2029)
6.3.3 World Menopausal Hormone Therapy Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Eli Lilly
7.1.1 Eli Lilly Details
7.1.2 Eli Lilly Major Business
7.1.3 Eli Lilly Menopausal Hormone Therapy Product and Services
7.1.4 Eli Lilly Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Eli Lilly Recent Developments/Updates
7.1.6 Eli Lilly Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Menopausal Hormone Therapy Product and Services
7.2.4 Pfizer Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Menopausal Hormone Therapy Product and Services
7.3.4 AbbVie Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Novo Nordisk
7.4.1 Novo Nordisk Details
7.4.2 Novo Nordisk Major Business
7.4.3 Novo Nordisk Menopausal Hormone Therapy Product and Services
7.4.4 Novo Nordisk Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novo Nordisk Recent Developments/Updates
7.4.6 Novo Nordisk Competitive Strengths & Weaknesses
7.5 Merck KGaA
7.5.1 Merck KGaA Details
7.5.2 Merck KGaA Major Business
7.5.3 Merck KGaA Menopausal Hormone Therapy Product and Services
7.5.4 Merck KGaA Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Merck KGaA Recent Developments/Updates
7.5.6 Merck KGaA Competitive Strengths & Weaknesses
7.6 Mylan
7.6.1 Mylan Details
7.6.2 Mylan Major Business
7.6.3 Mylan Menopausal Hormone Therapy Product and Services
7.6.4 Mylan Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Mylan Recent Developments/Updates
7.6.6 Mylan Competitive Strengths & Weaknesses
7.7 Bayer
7.7.1 Bayer Details
7.7.2 Bayer Major Business
7.7.3 Bayer Menopausal Hormone Therapy Product and Services
7.7.4 Bayer Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Bayer Recent Developments/Updates
7.7.6 Bayer Competitive Strengths & Weaknesses
7.8 Teva
7.8.1 Teva Details
7.8.2 Teva Major Business
7.8.3 Teva Menopausal Hormone Therapy Product and Services
7.8.4 Teva Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Teva Recent Developments/Updates
7.8.6 Teva Competitive Strengths & Weaknesses
7.9 Novartis
7.9.1 Novartis Details
7.9.2 Novartis Major Business
7.9.3 Novartis Menopausal Hormone Therapy Product and Services
7.9.4 Novartis Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Novartis Recent Developments/Updates
7.9.6 Novartis Competitive Strengths & Weaknesses
7.10 Abbott
7.10.1 Abbott Details
7.10.2 Abbott Major Business
7.10.3 Abbott Menopausal Hormone Therapy Product and Services
7.10.4 Abbott Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Abbott Recent Developments/Updates
7.10.6 Abbott Competitive Strengths & Weaknesses
7.11 Roche
7.11.1 Roche Details
7.11.2 Roche Major Business
7.11.3 Roche Menopausal Hormone Therapy Product and Services
7.11.4 Roche Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Roche Recent Developments/Updates
7.11.6 Roche Competitive Strengths & Weaknesses
7.12 Endo International
7.12.1 Endo International Details
7.12.2 Endo International Major Business
7.12.3 Endo International Menopausal Hormone Therapy Product and Services
7.12.4 Endo International Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Endo International Recent Developments/Updates
7.12.6 Endo International Competitive Strengths & Weaknesses
7.13 Ipsen
7.13.1 Ipsen Details
7.13.2 Ipsen Major Business
7.13.3 Ipsen Menopausal Hormone Therapy Product and Services
7.13.4 Ipsen Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Ipsen Recent Developments/Updates
7.13.6 Ipsen Competitive Strengths & Weaknesses
7.14 ANI Pharmaceuticals
7.14.1 ANI Pharmaceuticals Details
7.14.2 ANI Pharmaceuticals Major Business
7.14.3 ANI Pharmaceuticals Menopausal Hormone Therapy Product and Services
7.14.4 ANI Pharmaceuticals Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 ANI Pharmaceuticals Recent Developments/Updates
7.14.6 ANI Pharmaceuticals Competitive Strengths & Weaknesses
7.15 TherapeuticsMD
7.15.1 TherapeuticsMD Details
7.15.2 TherapeuticsMD Major Business
7.15.3 TherapeuticsMD Menopausal Hormone Therapy Product and Services
7.15.4 TherapeuticsMD Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 TherapeuticsMD Recent Developments/Updates
7.15.6 TherapeuticsMD Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Menopausal Hormone Therapy Industry Chain
8.2 Menopausal Hormone Therapy Upstream Analysis
8.3 Menopausal Hormone Therapy Midstream Analysis
8.4 Menopausal Hormone Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Menopausal Hormone Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Menopausal Hormone Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Menopausal Hormone Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Menopausal Hormone Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Menopausal Hormone Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Menopausal Hormone Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Menopausal Hormone Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Menopausal Hormone Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Menopausal Hormone Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Menopausal Hormone Therapy Players in 2022
Table 12. World Menopausal Hormone Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Menopausal Hormone Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Menopausal Hormone Therapy Player
Table 15. Menopausal Hormone Therapy Market: Company Product Type Footprint
Table 16. Menopausal Hormone Therapy Market: Company Product Application Footprint
Table 17. Menopausal Hormone Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Menopausal Hormone Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Menopausal Hormone Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Menopausal Hormone Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Menopausal Hormone Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Menopausal Hormone Therapy Revenue Market Share (2018-2023)
Table 23. China Based Menopausal Hormone Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Menopausal Hormone Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Menopausal Hormone Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Menopausal Hormone Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Menopausal Hormone Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Menopausal Hormone Therapy Revenue Market Share (2018-2023)
Table 29. World Menopausal Hormone Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Menopausal Hormone Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Menopausal Hormone Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Menopausal Hormone Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Menopausal Hormone Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Menopausal Hormone Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. Eli Lilly Basic Information, Area Served and Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Menopausal Hormone Therapy Product and Services
Table 38. Eli Lilly Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Eli Lilly Recent Developments/Updates
Table 40. Eli Lilly Competitive Strengths & Weaknesses
Table 41. Pfizer Basic Information, Area Served and Competitors
Table 42. Pfizer Major Business
Table 43. Pfizer Menopausal Hormone Therapy Product and Services
Table 44. Pfizer Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Pfizer Recent Developments/Updates
Table 46. Pfizer Competitive Strengths & Weaknesses
Table 47. AbbVie Basic Information, Area Served and Competitors
Table 48. AbbVie Major Business
Table 49. AbbVie Menopausal Hormone Therapy Product and Services
Table 50. AbbVie Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AbbVie Recent Developments/Updates
Table 52. AbbVie Competitive Strengths & Weaknesses
Table 53. Novo Nordisk Basic Information, Area Served and Competitors
Table 54. Novo Nordisk Major Business
Table 55. Novo Nordisk Menopausal Hormone Therapy Product and Services
Table 56. Novo Nordisk Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novo Nordisk Recent Developments/Updates
Table 58. Novo Nordisk Competitive Strengths & Weaknesses
Table 59. Merck KGaA Basic Information, Area Served and Competitors
Table 60. Merck KGaA Major Business
Table 61. Merck KGaA Menopausal Hormone Therapy Product and Services
Table 62. Merck KGaA Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Merck KGaA Recent Developments/Updates
Table 64. Merck KGaA Competitive Strengths & Weaknesses
Table 65. Mylan Basic Information, Area Served and Competitors
Table 66. Mylan Major Business
Table 67. Mylan Menopausal Hormone Therapy Product and Services
Table 68. Mylan Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Mylan Recent Developments/Updates
Table 70. Mylan Competitive Strengths & Weaknesses
Table 71. Bayer Basic Information, Area Served and Competitors
Table 72. Bayer Major Business
Table 73. Bayer Menopausal Hormone Therapy Product and Services
Table 74. Bayer Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Bayer Recent Developments/Updates
Table 76. Bayer Competitive Strengths & Weaknesses
Table 77. Teva Basic Information, Area Served and Competitors
Table 78. Teva Major Business
Table 79. Teva Menopausal Hormone Therapy Product and Services
Table 80. Teva Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Teva Recent Developments/Updates
Table 82. Teva Competitive Strengths & Weaknesses
Table 83. Novartis Basic Information, Area Served and Competitors
Table 84. Novartis Major Business
Table 85. Novartis Menopausal Hormone Therapy Product and Services
Table 86. Novartis Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Novartis Recent Developments/Updates
Table 88. Novartis Competitive Strengths & Weaknesses
Table 89. Abbott Basic Information, Area Served and Competitors
Table 90. Abbott Major Business
Table 91. Abbott Menopausal Hormone Therapy Product and Services
Table 92. Abbott Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Abbott Recent Developments/Updates
Table 94. Abbott Competitive Strengths & Weaknesses
Table 95. Roche Basic Information, Area Served and Competitors
Table 96. Roche Major Business
Table 97. Roche Menopausal Hormone Therapy Product and Services
Table 98. Roche Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Roche Recent Developments/Updates
Table 100. Roche Competitive Strengths & Weaknesses
Table 101. Endo International Basic Information, Area Served and Competitors
Table 102. Endo International Major Business
Table 103. Endo International Menopausal Hormone Therapy Product and Services
Table 104. Endo International Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Endo International Recent Developments/Updates
Table 106. Endo International Competitive Strengths & Weaknesses
Table 107. Ipsen Basic Information, Area Served and Competitors
Table 108. Ipsen Major Business
Table 109. Ipsen Menopausal Hormone Therapy Product and Services
Table 110. Ipsen Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Ipsen Recent Developments/Updates
Table 112. Ipsen Competitive Strengths & Weaknesses
Table 113. ANI Pharmaceuticals Basic Information, Area Served and Competitors
Table 114. ANI Pharmaceuticals Major Business
Table 115. ANI Pharmaceuticals Menopausal Hormone Therapy Product and Services
Table 116. ANI Pharmaceuticals Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. ANI Pharmaceuticals Recent Developments/Updates
Table 118. TherapeuticsMD Basic Information, Area Served and Competitors
Table 119. TherapeuticsMD Major Business
Table 120. TherapeuticsMD Menopausal Hormone Therapy Product and Services
Table 121. TherapeuticsMD Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Menopausal Hormone Therapy Upstream (Raw Materials)
Table 123. Menopausal Hormone Therapy Typical Customers
List of Figure
Figure 1. Menopausal Hormone Therapy Picture
Figure 2. World Menopausal Hormone Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Menopausal Hormone Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Menopausal Hormone Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Menopausal Hormone Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Menopausal Hormone Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Menopausal Hormone Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Menopausal Hormone Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Menopausal Hormone Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Menopausal Hormone Therapy Markets in 2022
Figure 27. United States VS China: Menopausal Hormone Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Menopausal Hormone Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Menopausal Hormone Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Menopausal Hormone Therapy Market Size Market Share by Type in 2022
Figure 31. Estrogen
Figure 32. Progesterone
Figure 33. World Menopausal Hormone Therapy Market Size Market Share by Type (2018-2029)
Figure 34. World Menopausal Hormone Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Menopausal Hormone Therapy Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Others
Figure 39. Menopausal Hormone Therapy Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Menopausal Hormone Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Menopausal Hormone Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Menopausal Hormone Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Menopausal Hormone Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Menopausal Hormone Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Menopausal Hormone Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Menopausal Hormone Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Menopausal Hormone Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Menopausal Hormone Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Menopausal Hormone Therapy Players in 2022
Table 12. World Menopausal Hormone Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Menopausal Hormone Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Menopausal Hormone Therapy Player
Table 15. Menopausal Hormone Therapy Market: Company Product Type Footprint
Table 16. Menopausal Hormone Therapy Market: Company Product Application Footprint
Table 17. Menopausal Hormone Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Menopausal Hormone Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Menopausal Hormone Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Menopausal Hormone Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Menopausal Hormone Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Menopausal Hormone Therapy Revenue Market Share (2018-2023)
Table 23. China Based Menopausal Hormone Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Menopausal Hormone Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Menopausal Hormone Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Menopausal Hormone Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Menopausal Hormone Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Menopausal Hormone Therapy Revenue Market Share (2018-2023)
Table 29. World Menopausal Hormone Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Menopausal Hormone Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Menopausal Hormone Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Menopausal Hormone Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Menopausal Hormone Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Menopausal Hormone Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. Eli Lilly Basic Information, Area Served and Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Menopausal Hormone Therapy Product and Services
Table 38. Eli Lilly Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Eli Lilly Recent Developments/Updates
Table 40. Eli Lilly Competitive Strengths & Weaknesses
Table 41. Pfizer Basic Information, Area Served and Competitors
Table 42. Pfizer Major Business
Table 43. Pfizer Menopausal Hormone Therapy Product and Services
Table 44. Pfizer Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Pfizer Recent Developments/Updates
Table 46. Pfizer Competitive Strengths & Weaknesses
Table 47. AbbVie Basic Information, Area Served and Competitors
Table 48. AbbVie Major Business
Table 49. AbbVie Menopausal Hormone Therapy Product and Services
Table 50. AbbVie Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AbbVie Recent Developments/Updates
Table 52. AbbVie Competitive Strengths & Weaknesses
Table 53. Novo Nordisk Basic Information, Area Served and Competitors
Table 54. Novo Nordisk Major Business
Table 55. Novo Nordisk Menopausal Hormone Therapy Product and Services
Table 56. Novo Nordisk Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novo Nordisk Recent Developments/Updates
Table 58. Novo Nordisk Competitive Strengths & Weaknesses
Table 59. Merck KGaA Basic Information, Area Served and Competitors
Table 60. Merck KGaA Major Business
Table 61. Merck KGaA Menopausal Hormone Therapy Product and Services
Table 62. Merck KGaA Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Merck KGaA Recent Developments/Updates
Table 64. Merck KGaA Competitive Strengths & Weaknesses
Table 65. Mylan Basic Information, Area Served and Competitors
Table 66. Mylan Major Business
Table 67. Mylan Menopausal Hormone Therapy Product and Services
Table 68. Mylan Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Mylan Recent Developments/Updates
Table 70. Mylan Competitive Strengths & Weaknesses
Table 71. Bayer Basic Information, Area Served and Competitors
Table 72. Bayer Major Business
Table 73. Bayer Menopausal Hormone Therapy Product and Services
Table 74. Bayer Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Bayer Recent Developments/Updates
Table 76. Bayer Competitive Strengths & Weaknesses
Table 77. Teva Basic Information, Area Served and Competitors
Table 78. Teva Major Business
Table 79. Teva Menopausal Hormone Therapy Product and Services
Table 80. Teva Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Teva Recent Developments/Updates
Table 82. Teva Competitive Strengths & Weaknesses
Table 83. Novartis Basic Information, Area Served and Competitors
Table 84. Novartis Major Business
Table 85. Novartis Menopausal Hormone Therapy Product and Services
Table 86. Novartis Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Novartis Recent Developments/Updates
Table 88. Novartis Competitive Strengths & Weaknesses
Table 89. Abbott Basic Information, Area Served and Competitors
Table 90. Abbott Major Business
Table 91. Abbott Menopausal Hormone Therapy Product and Services
Table 92. Abbott Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Abbott Recent Developments/Updates
Table 94. Abbott Competitive Strengths & Weaknesses
Table 95. Roche Basic Information, Area Served and Competitors
Table 96. Roche Major Business
Table 97. Roche Menopausal Hormone Therapy Product and Services
Table 98. Roche Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Roche Recent Developments/Updates
Table 100. Roche Competitive Strengths & Weaknesses
Table 101. Endo International Basic Information, Area Served and Competitors
Table 102. Endo International Major Business
Table 103. Endo International Menopausal Hormone Therapy Product and Services
Table 104. Endo International Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Endo International Recent Developments/Updates
Table 106. Endo International Competitive Strengths & Weaknesses
Table 107. Ipsen Basic Information, Area Served and Competitors
Table 108. Ipsen Major Business
Table 109. Ipsen Menopausal Hormone Therapy Product and Services
Table 110. Ipsen Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Ipsen Recent Developments/Updates
Table 112. Ipsen Competitive Strengths & Weaknesses
Table 113. ANI Pharmaceuticals Basic Information, Area Served and Competitors
Table 114. ANI Pharmaceuticals Major Business
Table 115. ANI Pharmaceuticals Menopausal Hormone Therapy Product and Services
Table 116. ANI Pharmaceuticals Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. ANI Pharmaceuticals Recent Developments/Updates
Table 118. TherapeuticsMD Basic Information, Area Served and Competitors
Table 119. TherapeuticsMD Major Business
Table 120. TherapeuticsMD Menopausal Hormone Therapy Product and Services
Table 121. TherapeuticsMD Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Menopausal Hormone Therapy Upstream (Raw Materials)
Table 123. Menopausal Hormone Therapy Typical Customers
List of Figure
Figure 1. Menopausal Hormone Therapy Picture
Figure 2. World Menopausal Hormone Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Menopausal Hormone Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Menopausal Hormone Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Menopausal Hormone Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Menopausal Hormone Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Menopausal Hormone Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Menopausal Hormone Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Menopausal Hormone Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Menopausal Hormone Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Menopausal Hormone Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Menopausal Hormone Therapy Markets in 2022
Figure 27. United States VS China: Menopausal Hormone Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Menopausal Hormone Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Menopausal Hormone Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Menopausal Hormone Therapy Market Size Market Share by Type in 2022
Figure 31. Estrogen
Figure 32. Progesterone
Figure 33. World Menopausal Hormone Therapy Market Size Market Share by Type (2018-2029)
Figure 34. World Menopausal Hormone Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Menopausal Hormone Therapy Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Others
Figure 39. Menopausal Hormone Therapy Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
